On a TTM 2026Q1 basis, DNA is improving on both revenue and margins, though the magnitude is still moderate — profit is at an all-time high. This signal only becomes convincing if the improvement continues through the next few periods.
Revenue TTM
VND 2,800bn
+6.3%
Net Margin
5.34%
+0.0pp year on year
ROE
16.7%
TTM
Related News